UNSPSC 51143706: Calcium gluconate/niacinamide/phenobarbital

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN900. This VA Drug Class (CN900) classifies this compound as belonging to the group CNS MEDICATIONS, OTHER.

UNSPSC 51143706 Calcium gluconate/niacinamide/phenobarbital is a Commodity code that in practice covers pharmaceutical procurement and related health-supply systems across state and local health agencies, though recent opportunities show misalignment between the code's nominal composition and the products actually being procured. State and local buyers under this code are acquiring naloxone and drug deactivation systems for community health initiatives, generic pharmaceuticals and over-the-counter products through cooperative purchasing vehicles, and conducting market research for direct-to-manufacturer prescription programs. Issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance), reflecting a mix of county-level direct procurement and state-coordinated procurement for multiple jurisdictions.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with response due July 26, 2023. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities and market intelligence on implementing a Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions program, with no formal competitive evaluation but exploratory information-gathering to inform future RFP development. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local government facilities, with proposals due March 26, 2026, evaluating vendors on fixed pricing, compliance with administrative requirements, EDI capability, and price competitiveness weighted at 75 percent.